MIRA INFORM REPORT

 

 

Report Date :

21.02.2011

 

IDENTIFICATION DETAILS

 

Name :

LABORATORIOS ANDROMACO S.A.I.C.I. 

 

 

Registered Office :

Avda.Ingeniero Huergo City of Buenos Aires

 

 

Country :

Argentina

 

 

Date of Incorporation :

06.02.1941

 

 

Legal Form :

Limited Company

 

 

Line of Business :

Processing & marketing of medical specialties

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 


 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2010

 

Country Name

Previous Rating

                   (01.04.2010)                  

Current Rating

(30.06.2010)

Argentina

b1

b1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


Registered Name

 

LABORATORIOS ANDROMACO S.A.I.C.I.

CUIT No.: 30-50450732-3

 

 

Summary

 

INCORPORATED  IN  1941,   BEGINNER OF ACTIVITIES,   NO FINANCIAL  DATA PROVIDED, OPERATES WITHIN A GOOD LEVEL,   NO NEGATIVE ANTECEDENTS,   APT FOR MODERATE CREDITS WITH GUARANTEES.   FOR GREATER SUMS REQUEST ADDITIONAL GUARANTEES.

 

 

Operations

 

MEDICAL SPECIALTIES

PROCESSING

MARKETING

 

 

Legal structure

 

Legal Business Limited Company

Incorporated:                 06/02/1941

Registered R.P.C.:         24/04/1941

Duration:                       07/03/2011

End of fiscal yr:              30/06

 

 

Contact

 

Legal, operative and administrative address: Avda.Ingeniero Huergo City of Buenos Aires, Argentina.

 

Phone:              (54-011)   4307-6000   (lineas rotativas)

Fax.:                 (54-011) 4352-0725

E-mail:              ademartino@andromaco.com.ar

 

 


Partners

 

President:                     ROVIRALTA ALEJANDRO

Vice president:              ROVIRALTA ALEJANDRO MARIANO

Director:                        ROVIRALTA ESCALANTE PABLO

Director:                        ROVIRALTA IGNACIO

Alternate Director:          ESCALANTE DE ROVIRALTA LUCIA

 

The first two exhibits will have charge of the management and administration of the company,   in its capacity as manager with the indiscriminate use of the corporate signature.

 

 

Corporate Stock

 

CORPORATE STOCK $ 4.915.451.-

 

 

Personal Information

 

ROVIRALTA ALEJANDRO:

argentinian, married, born in 22/11/1926, DNI.No. 15.228.975 (CUIT No.20-93227431-1)  with address in Arribenos 1315,  Buenos Aires City.

 

The same history through the following companies:

 

DESARROLLOS NORTE S.A. Director PROXIMITAS S.A. Director

ROVIRALTA ALEJANDRO MARIANO:

 

argentinian, married, born in 15/08/1953, DNI.No. 11.076.164 (CUIT No.20-11076164-4) with address in Blanco Encalada 1049,  Buenos Aires City.

 

The same history records through the following companies:

 

DESARROLLOS NORTE S.A.    President
RUTAM S.A.F.C.I.                     President
ARAWAK S.A.                          Alternate Director

ANDROQUIMICA S.A.                President

 


 

History

 

While the incumbent directors of circumventing the delivery of all types of information related to it,  based on information available in our power is being able to senalarsele as initiator of the activities being conducted by, observing that this will located in the direction you exposed.

 

In the above,   it adds that it exerts a controlling interest in firms IADELPA SA and LABORATORIOS ANDROMACO DO BRASIL S.A.,   being connected to ANDROQUIMICA SA

 

 

Economic-Financial Position

 

Due to these reasons in due course,  it was not possible to make contact with balance or exemplary figures updated,  the last official media presented to the finished on 30/06/2008 which is totally outdated and therefore this does not deserve any consideration.

 

Other common sources of consultation,  no current data,  going beyond that for several years been operating with high debt levels,  only discrete finally getting results.

 

BUILDINGS:

The fixed assets of the company,   including the large building that houses which, because of its location,  it is important to realizable value.

 

Unable to contact the appropriate documentation to verify if it is free of liens.

 

 

Parent/Related Companies

 

·         ANDROQUIMICA S.A. (Related)

·         IADELPA S.A. (Controlled)

·         LABORATORIOS SUR LIMITADA (Related)

·         LABORATORIOS ANDROMADO DO BRASIL S.A. (Controlled)

 

 

Evolution and Results

 

The specific purposes of the owner concerned with the manufacture of human medicines and pharmaceutical products,  being in turn enabled to make cosmetics, perfumes and toiletry products.

 

To this end it is located at the address set out,  where it occupies a very old building dating,  although it has undergone several reforms designed to keep you in optimum conditions for the development of activities that it faces.


Specific imports from Belgium,  China,  India and Germany among other countries, with exports to various member countries of Mercosur.

 

*550 employees

 

MAIN SUPPLIERS:

·         TALLERES GRAFICOS MORALES

·         LEO PHARMACEUTICAL S.A. BASF ARGENTINA S.A.

 

Foreign trade

In the last twelve months in office, according to the following details:

 

Belgium          u $ s.   1.870.351

CHINA              u $  s.  625.598

INDIA                u $  s.  573.115

OTHER             u $  s.  1.449.254

 

Payment records and CREIDT RISK

 

BANCO PATAGONIA S.A.                     Branch San Telmo

BANCO SANTANDER RIO                     Principal office

STANDARD BANK                                 Principal office

BBVA BANCO FRANCES                      Principal office

BANCO SUPERVIELLE                         Principal office

BANCO ITAU                                         Principal office

 

 

Credit risk

 

SANTANDER RIO                      11/2010             1                      $  13.888.200

BCO.PATAGONIA                     11/2010                                     %   6.213.000

SUPERVIELLE AMERICAN                                            1                      $   2.118.800

EXPRESS                                 11/2010             1                      $     656.200

FF PVCRED.                             11/2010             1                      $     116.200

COMAFI                                    11/2010             1                      $      40.100

 

Situation 1   normal

 

 

INSURANCE

 

·         ZURICH CIA.DE SEGUROS S.A.

·         LA MERIDIONAL CIA.DE  SEGUROS GENERALES S.A.

 

 

 

Concept

 

From its beginnings and at commercial level is related to the firms of this and other places, most of which provide credit support without objections until the present on the payment methods it supports.

* COMPLIANCE: WITHOUT OBJECTIONS

 

 

Final opinion

 

Based on the present review,   is arrived at the conclusion that the credit deal with this society is possible,  within sum of moderate economic level,  in the conditions that are of    habitual practices.

 

In operations of greater importance,  the request of suitable endorsement is advisable,  that guarantee the normal return of the set out capitals.

 

APT FOR CREDITS.

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.18

UK Pound

1

Rs.73.04

Euro

1

Rs.61.43

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.